Poly Medicure Limited

Symbol: POLYMED.NS

NSE

1585.05

INR

Market price today

  • 61.3484

    P/E Ratio

  • 311.8541

    PEG Ratio

  • 152.12B

    MRK Cap

  • 0.00%

    DIV Yield

Poly Medicure Limited (POLYMED-NS) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.65%

Operating Profit Margin

0.25%

Net Profit Margin

0.19%

Return on Assets

0.00%

Return on Equity

0.19%

Return on Capital Employed

0.00%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO:Mr. Himanshu Baid
Full-time employees:2339
City:New Delhi
Address:232B Okhla Industrial Estate
IPO:2011-12-07
CIK:

Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal tubes, tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. In addition, it offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. Further, it provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, and universal caps. The company was incorporated in 1995 and is based in New Delhi, India.

General Outlook

When we look at how much money they make before expenses, they keep 0.650% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.248%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.191%. This tells us they're good at keeping money after all costs.

Return on Investments

Poly Medicure Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.193%.

Stock Prices

Poly Medicure Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $1595.05, while its low point bottomed out at $1564.8. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Poly Medicure Limited's stock market.

Profitability Ratios

POLYMED.NS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 25.06% underscores its earnings before tax deductions. The effective tax rate stands at 23.93%, revealing its tax efficiency. The net income per EBT, 76.07%, and the EBT per EBIT, 101.03%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 24.81%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin25.06%
Effective Tax Rate23.93%
Net Income per EBT76.07%
EBT per EBIT101.03%
EBIT per Revenue24.81%

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 10.15, and free cash flow per share, 10.15, depict cash generation on a per-share basis. The cash per share value, 29.17, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.07, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share10.15
Free Cash Flow per Share10.15
Cash per Share29.17
Operating Cash Flow Sales Ratio0.07
Free Cash Flow to Operating Cash Flow Ratio1.00

Debt and Leverage Ratios

An interest coverage of 30.75 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Interest Coverage30.75

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 21.63%, indicates top-line expansion, while the gross profit growth, 46.66%, reveals profitability trends. EBIT growth, 30.78%, and operating income growth, 30.78%, offer insights into operational profitability progression. The net income growth, 22.37%, showcases bottom-line expansion, and the EPS growth, 22.32%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth21.63%
Gross Profit Growth46.66%
EBIT Growth30.78%
Operating Income Growth30.78%
Net Income Growth22.37%
EPS Growth22.32%
EPS Diluted Growth22.27%
Weighted Average Shares Growth0.03%
Weighted Average Shares Diluted Growth0.06%
Dividends per Share Growth0.21%
Operating Cash Flow Growth54.55%
Free Cash Flow Growth-50.90%
10-Year Revenue Growth per Share301.64%
5-Year Revenue Growth per Share102.19%
3-Year Revenue Growth per Share53.31%
10-Year Operating CF Growth per Share351.33%
5-Year Operating CF Growth per Share134.26%
3-Year Operating CF Growth per Share34.53%
10-Year Net Income Growth per Share579.63%
5-Year Net Income Growth per Share133.60%
3-Year Net Income Growth per Share72.04%
10-Year Shareholders Equity Growth per Share914.10%
5-Year Shareholders Equity Growth per Share237.60%
3-Year Shareholders Equity Growth per Share162.71%
10-Year Dividend per Share Growth per Share566.49%
5-Year Dividend per Share Growth per Share315.33%
3-Year Dividend per Share Growth per Share-48.07%
Receivables Growth-1.92%
Inventory Growth23.93%
Asset Growth14.55%
Book Value per Share Growth14.14%
Debt Growth17.61%
R&D Expense Growth-5.16%
SGA Expenses Growth18.13%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 11.40, and the price to book ratio, 11.40, reflect the market's valuation relative to the company's book value. The price to sales ratio, 11.70, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 156.73, and price to operating cash flows, 156.68, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio11.40
Price to Book Ratio11.40
Price to Sales Ratio11.70
Price Cash Flow Ratio156.68
Price Earnings to Growth Ratio311.85
Enterprise Value Multiple37.46
Price Fair Value11.40
Price to Operating Cash Flow Ratio156.68
Price to Free Cash Flows Ratio156.73
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Poly Medicure Limited (POLYMED.NS) on the NSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 61.348 in 2024.

What is the ticker symbol of Poly Medicure Limited stock?

The ticker symbol of Poly Medicure Limited stock is POLYMED.NS.

What is company IPO date?

IPO date of Poly Medicure Limited is 2011-12-07.

What is company current share price?

Current share price is 1585.050 INR.

What is stock market cap today?

The market cap of stock today is 152119467570.000.

What is PEG ratio in 2024?

The current 311.854 is 311.854 in 2024.

What is the number of employees in 2024?

In 2024 the company has 2339.